Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Exchange Rate Effect: 2014-2024

Historic Exchange Rate Effect for Cartesian Therapeutics (RNAC) over the last 11 years, with Dec 2024 value amounting to -$21,000.

  • Cartesian Therapeutics' Exchange Rate Effect rose 33.33% to -$10,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19,000, marking a year-over-year increase of 90.00%. This contributed to the annual value of -$21,000 for FY2024, which is 60.38% up from last year.
  • Per Cartesian Therapeutics' latest filing, its Exchange Rate Effect stood at -$21,000 for FY2024, which was up 60.38% from -$53,000 recorded in FY2023.
  • In the past 5 years, Cartesian Therapeutics' Exchange Rate Effect registered a high of $20,000 during FY2022, and its lowest value of -$58,000 during FY2020.
  • Over the past 3 years, Cartesian Therapeutics' median Exchange Rate Effect value was -$21,000 (recorded in 2024), while the average stood at -$18,000.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first skyrocketed by 766.67% in 2022, then crashed by 365.00% in 2023.
  • Over the past 5 years, Cartesian Therapeutics' Exchange Rate Effect (Yearly) stood at -$58,000 in 2020, then surged by 94.83% to -$3,000 in 2021, then skyrocketed by 766.67% to $20,000 in 2022, then slumped by 365.00% to -$53,000 in 2023, then spiked by 60.38% to -$21,000 in 2024.